Rapid communications in mass spectrometry : RCM · 2026
Mass Spectrometry-Based Proteomics to Understand Immune Thrombocytopenic Purpura: A Review.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Raza Syed Kashif, Iqbal Ayesha
Аннотация
BACKGROUND: Immune thrombocytopenic purpura (ITP) is an autoimmune bleeding disorder with substantial variability in bleeding manifestations and a generally low risk of fatal outcomes. Diagnosis is based on exclusion and is supported by thrombocytopenia in peripheral blood and characteristic megakaryocytic findings in bone marrow examination. In many adults, treatment remains suboptimal, and morbidity may result from both bleeding and the adverse effects of immunosuppressive therapies.
RATIONALE: Identifying the underlying disease process is essential for improving diagnostic precision, developing targeted therapies, and enhancing patient outcomes.
OBJECTIVE: This review summarizes mass spectrometry-based proteomics studies investigating the pathogenesis of ITP and their diagnostic, prognostic, and therapeutic implications.
CONCLUSION: Despite significant clinical heterogeneity, proteomic research in ITP remains limited, underscoring the need for comprehensive molecular studies to better elucidate disease mechanisms.
RATIONALE: Identifying the underlying disease process is essential for improving diagnostic precision, developing targeted therapies, and enhancing patient outcomes.
OBJECTIVE: This review summarizes mass spectrometry-based proteomics studies investigating the pathogenesis of ITP and their diagnostic, prognostic, and therapeutic implications.
CONCLUSION: Despite significant clinical heterogeneity, proteomic research in ITP remains limited, underscoring the need for comprehensive molecular studies to better elucidate disease mechanisms.